-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In brain diseases such as Alzheimer's, these synaptic connections that store our precious memories are known to collapse and disappear prematurely
Neurobiologists at the University of California San Diego (University of California San Diego) have now discovered the long-sought mechanism for maintaining glutamate synapses
Despite great efforts, drug discovery for the treatment of Alzheimer's disease has been unsuccessful
The findings of this study were published in the journal Science Advances on August 18.
Glutamate synapses are highly polarized structures.
They were curious about whether these components are related to synaptic degeneration, and tested whether amyloid, a key driver of synapse loss in Alzheimer's disease, affects the function or interaction of these proteins
"It's like beta amyloid discovered the Achilles heel of our synapses long ago," Professor Zou said
When the researchers removed Vangl2 from neurons, they found that whether in neuron culture or in animals exposed to amyloid oligomers, beta amyloid no longer caused synaptic degradation
To further verify the hypothesis that this basic signaling pathway is the main target of synaptic degeneration in Alzheimer's disease, the researchers used 5XFAD mice, a well-known β-amyloid pathological mouse model
These exciting results indicate that the PCP pathway is the direct target of amyloid-induced synaptic loss in Alzheimer's disease
"Amyloid pathology and synapse loss usually occur in the early stages of Alzheimer's disease.
The neuroinflammation reflected by the activation of astrocytes and microglia is also a pathological feature of Alzheimer's disease.
"This finding may be applicable to general synaptic degeneration, because the PCP component may be the direct synaptic loss that mediates other neurodegenerative diseases (such as Parkinson's disease and Lou Gehrig's disease).
Journal Reference :
Bo Feng, Andiara E.